TREATMENT OF MULTIPLE-MYELOMA - A RANDOMIZED STUDY OF 3 DIFFERENT REGIMENS

被引：22

作者：

TRIBALTO, M

AMADORI, S

CANTONETTI, M

FRANCHI, A

PAPA, G

PILERI, A

BOCCADORO, M

DAMMACCO, F

VACCA, A

CENTURIONI, R

LEONI, P

MARTELLI, M

AVERSA, F

TONATO, M

DERIU, L

GUARINO, S

NERI, A

RIDOLFINI, FP

MANDELLI, F

机构：

[1] UNIV LA SAPIENZA,INST HEMATOL,ROMA,ITALY

[2] UNIV TURIN,INST HEMATOL,I-10124 TURIN,ITALY

[3] UNIV BARI,INST CLIN MED,I-70124 BARI,ITALY

[4] UNIV ANCONA,INST PATOL MED,I-60100 ANCONA,ITALY

[5] UNIV PERUGIA,INST CLIN MED,I-06100 PERUGIA,ITALY

[6] POLICLIN MONTELUCE,INST CHEMOTHERAPY,PERUGIA,ITALY

[7] OSPED CIVILE S MARIA GORETTI,DEPT HEMATOL,LATINA,ITALY

[8] OSPED RIUNITI,DEPT HEMATOL,REGGIO CALABRIA,ITALY

[9] OSPED GEN PROV SORA,DEPT HEMATOL,SORA,ITALY

来源：

LEUKEMIA RESEARCH | 1985年 / 9卷 / 08期

关键词：

D O I：

10.1016/0145-2126(85)90075-X

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1043 / 1049

页数：7

共 20 条

[11]

BERGSAGEL DE, 1972, CAN MED ASSOC J, V107, P851

[12] IMPROVED SURVIVAL TIMES IN MULTIPLE-MYELOMA TREATED WITH MELPHALAN, PREDNISONE, CYCLOPHOSPHAMIDE, VINCRISTINE AND BCNU - M-2 PROTOCOL [J].

CASE, DC ;

LEE, BJ ;

CLARKSON, BD .

AMERICAN JOURNAL OF MEDICINE, 1977, 63 (06) :897-903

[13]

DURIE BGM, 1980, BLOOD, V55, P364

[14]

DURIE BGM, 1975, CANCER, V36, P842, DOI 10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO

[15]

2-U

[16] NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].

KAPLAN, EL ;

MEIER, P .

JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481

[17] DESIGN AND ANALYSIS OF RANDOMIZED CLINICAL-TRIALS REQUIRING PROLONGED OBSERVATION OF EACH PATIENT .1. INTRODUCTION AND DESIGN [J].

PETO, R ;

PIKE, MC ;

ARMITAGE, P ;

BRESLOW, NE ;

COX, DR ;

HOWARD, SV ;

MANTEL, N ;

MCPHERSON, K ;

PETO, J ;

SMITH, PG .

BRITISH JOURNAL OF CANCER, 1976, 34 (06) :585-612

[18]

SALMON SE, 1976, CANCER TREAT REP, V60, P789

[19]

SALMON SE, 1981, BLOOD S, V54, pA207

[20]

TRIBALTO M, 1983, CHEMIOTERAPIA, V2, P376

← 1 2 →